FDA approves popular diabetes medicine to be sold as weight-loss drug in US
The Food and Drug Administration approved Wegovy, a higher-dose version of Novo Nordisk's diabetes drug semaglutide, for long-term weight … Read more at 6abc.com
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
